Reference
Chen B, et al. Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis. Journal of Clinical Medicine 11 : 6686, No. 22, Nov 2022. Available from: URL: https://www.mdpi.com/journal/jcm
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1999, 20 (2024). https://doi.org/10.1007/s40278-024-54329-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-54329-6